Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Patent-Pending AI Mental Health Tracker Targeting $400 Billion Market
Medical Care Technologies (OTC PINK:MDCE) has announced the development of a patent-pending AI Mental Health Tracker, targeting the $400 billion global mental health market. The innovative platform utilizes advanced technologies including high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to detect psychological distress markers.
The technology is designed to operate through smartphones and webcams, offering accessible mental health diagnostics worldwide. MDCE plans to integrate this tracker into its multi-vertical health platform, with a beta app launch scheduled for 2026. The solution aims to serve various sectors including telehealth, education, military, and workplace wellness programs.
Medical Care Technologies (OTC PINK:MDCE) ha annunciato lo sviluppo di un AI Mental Health Tracker con brevetto in attesa, rivolto al mercato globale della salute mentale valutato $400 billion. La piattaforma innovativa sfrutta tecnologie avanzate come il tracciamento ad alta frequenza dei punti del viso, l'analisi temporale delle micro‑espressioni e reti neurali per il riconoscimento delle emozioni, al fine di individuare indicatori di disagio psicologico.
La soluzione è concepita per funzionare tramite smartphone e webcam, rendendo le diagnosi di salute mentale accessibili a livello mondiale. MDCE prevede di integrare questo tracker nella sua piattaforma sanitaria multi‑verticale, con il lancio della versione beta previsto per il 2026. L'obiettivo è servire diversi settori, tra cui telemedicina, istruzione, ambito militare e programmi di benessere aziendale.
Medical Care Technologies (OTC PINK:MDCE) ha anunciado el desarrollo de un AI Mental Health Tracker con patente pendiente, dirigido al mercado global de salud mental valorado en $400 billion. La plataforma innovadora emplea tecnologías avanzadas como el seguimiento facial de alta frecuencia, el análisis temporal de microexpresiones y redes neuronales de reconocimiento emocional para detectar marcadores de malestar psicológico.
La tecnología está diseñada para operar mediante smartphones y webcams, ofreciendo diagnósticos de salud mental accesibles en todo el mundo. MDCE planea integrar este rastreador en su plataforma sanitaria multi‑vertical, con el lanzamiento de la aplicación beta previsto para 2026. La solución apunta a atender diversos sectores, incluidos telesalud, educación, fuerzas armadas y programas de bienestar laboral.
Medical Care Technologies (OTC PINK:MDCE)는 특허 출원 중인 AI 정신건강 트래커 개발을 발표했으며, 표적 시장은 $400 billion 규모의 글로벌 정신건강 시장입니다. 이 혁신적인 플랫폼은 고속 프레임 얼굴 랜드마크 추적, 시간적 마이크로표정 분석, 감정 인식 신경망 등 첨단 기술을 활용해 심리적 고통의 지표를 감지합니다.
해당 기술은 스마트폰과 웹캠을 통해 작동하도록 설계되어 전 세계적으로 접근 가능한 정신건강 진단을 제공합니다. MDCE는 이 트래커를 다중 수직 통합 헬스 플랫폼에 통합할 계획이며, 베타 앱은 2026년 출시 예정입니다. 솔루션은 원격의료, 교육, 군대, 직장 내 웰니스 프로그램 등 다양한 분야에 서비스를 제공하는 것을 목표로 합니다.
Medical Care Technologies (OTC PINK:MDCE) a annoncé le développement d'un AI Mental Health Tracker en instance de brevet, visant le marché mondial de la santé mentale estimé à $400 billion. La plateforme innovante utilise des technologies avancées telles que le suivi des repères faciaux à haute fréquence, l'analyse temporelle des micro‑expressions et des réseaux neuronaux de reconnaissance des émotions pour détecter des marqueurs de détresse psychologique.
La technologie est conçue pour fonctionner via smartphones et webcams, offrant un diagnostic de santé mentale accessible dans le monde entier. MDCE prévoit d'intégrer ce traceur à sa plateforme de santé multi‑verticale, avec un lancement de l'application bêta prévu pour 2026. La solution vise à desservir divers secteurs, notamment la télésanté, l'éducation, le militaire et les programmes de bien‑être en entreprise.
Medical Care Technologies (OTC PINK:MDCE) hat die Entwicklung eines patentangemeldeten AI Mental Health Tracker angekündigt, der auf den globalen Markt für psychische Gesundheit im Volumen von $400 billion abzielt. Die innovative Plattform nutzt fortschrittliche Technologien wie hochfrequentes Tracking von Gesichtspunkten, zeitliche Mikro‑Expressions‑Analyse und emotionserkennende neuronale Netze, um Anzeichen psychischer Belastung zu erkennen.
Die Technologie ist so konzipiert, dass sie über Smartphones und Webcams funktioniert und weltweit zugängliche Diagnostik für psychische Gesundheit bietet. MDCE plant, diesen Tracker in seine Multi‑Vertical‑Gesundheitsplattform zu integrieren, mit einem Beta‑App‑Start für 2026. Die Lösung soll verschiedene Sektoren bedienen, darunter Telemedizin, Bildung, Militär und betriebliche Gesundheitsprogramme.
- Targeting large addressable market worth $400 billion
- Patent-pending technology leveraging advanced AI capabilities
- Non-invasive, scalable solution accessible through common devices
- Multiple potential revenue streams across telehealth, education, military, and workplace sectors
- Product still in development with beta launch not until 2026
- Faces regulatory and approval uncertainties
- Operating in highly competitive digital health market
MESA, ARIZONA / ACCESS Newswire / September 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an innovator in AI-powered healthcare technologies, today announced its AI Mental Health Tracker, a breakthrough solution designed to transform how anxiety, depression, and PTSD are detected and monitored. Visit the official site for more details at https://medicalcaretechnologies.com.
The. patent pending proprietary platform will leverage high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to uncover subclinical signs of psychological distress often missed by traditional screenings. With the ability to operate seamlessly through smartphones and webcams, this tool provides scalable, cost-effective access to real-time mental health diagnostics worldwide.
The global mental health market is valued at more than
"Mental health remains one of the most underserved areas in global healthcare," said Marshall Perkins III. "Our AI solution has the potential to revolutionize early detection, improve access, and dramatically reduce risk."
MDCE plans to integrate the AI Mental Health Tracker into its multi-vertical health platform, with a beta app launch targeted for 2026.
Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of federal securities laws. Actual results may differ materially due to risks and uncertainties, including market conditions, regulatory approvals, and product development timelines. Medical Care Technologies Inc. undertakes no obligation to update these statements except as required by law.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
FAQ
What is MDCE's new AI Mental Health Tracker and how does it work?
When will MDCE's AI Mental Health Tracker be available to the public?
What is the market size for MDCE's mental health technology?
Which sectors will MDCE's AI Mental Health Tracker target?
How does MDCE's AI Mental Health Tracker improve upon traditional mental health screening?
